altimmune
announce
third
quarter
financial
results
november
gaithersburg
globe
newswire
altimmune
nasdaq
alt
biopharmaceutical
company
today
announced
release
third
quarter
financial
results
tuesday
november
altimmune
management
host
conference
call
investors
beginning
et
tuesday
november
discuss
financial
results
provide
business
update
conference
call
details
date
tuesday
november
time
eastern
time
domestic
international
conference
id
webcast
http
altimmune
altimmune
clinical
stage
biopharmaceutical
company
focused
developing
intranasal
vaccines
immune
modulating
therapies
treatments
liver
disease
diverse
pipeline
includes
proprietary
intranasal
vaccines
anthrax
influenza
intranasal
immune
modulating
therapeutic
next
generation
peptide
therapeutics
nash
chronic
hepatitis
b
information
altimmune
please
visit
